1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Spastic Diplegia Cerebral Palsy Global Clinical Trials Review, H2, 2014

Spastic Diplegia Cerebral Palsy Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Spastic Diplegia Cerebral Palsy Global Clinical Trials Review, H2, 2014" provides data on the Spastic Diplegia Cerebral Palsy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Spastic Diplegia Cerebral Palsy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Spastic Diplegia Cerebral Palsy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Spastic Diplegia Cerebral Palsy Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Spastic Diplegia Cerebral Palsy 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Spastic Diplegia Cerebral Palsy to Central Nervous System Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Spastic Diplegia Cerebral Palsy to Central Nervous System Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Subjects Recruited Over a Period of Time 21
Clinical Trial Overview of Top Institutes / Government 22
National Taiwan University Hospital 22
Clinical Trial Overview of National Taiwan University Hospital 22
National Institute of Neurological Disorders and Stroke 23
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 23
Nanjing Hospital 24
Clinical Trial Overview of Nanjing Hospital 24
Thammasat University 25
Clinical Trial Overview of Thammasat University 25
Ahvaz Jundishapur University of Medical Sciences 26
Clinical Trial Overview of Ahvaz Jundishapur University of Medical Sciences 26
University of Heidelberg 27
Clinical Trial Overview of University of Heidelberg 27
Universita degli Studi di Modena e Reggio Emilia 28
Clinical Trial Overview of Universita degli Studi di Modena e Reggio Emilia 28
Manipal University 29
Clinical Trial Overview of Manipal University 29
Shriners Hospitals for Children 30
Clinical Trial Overview of Shriners Hospitals for Children 30
Five Key Clinical Profiles 31
Appendix 45
Abbreviations 45
Definitions 45
Research Methodology 46
Secondary Research 46
About GlobalData 47
Contact Us 47
Disclaimer 47
Source 47

List of Tables
Spastic Diplegia Cerebral Palsy Therapeutics, Global, Clinical Trials by Region, 2014* 6
Spastic Diplegia Cerebral Palsy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Spastic Diplegia Cerebral Palsy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials, Europe, Top Countries, 2014* 10
Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 12
Proportion of Spastic Diplegia Cerebral Palsy to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 13
Spastic Diplegia Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Spastic Diplegia Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Spastic Diplegia Cerebral Palsy to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 16
Spastic Diplegia Cerebral Palsy Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Spastic Diplegia Cerebral Palsy Therapeutics, Global, Clinical Trials by Phase, 2014* 18
Spastic Diplegia Cerebral Palsy Therapeutics, Global, Clinical Trials by Trial Status, 2014* 19
Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials, Global, by End Point Status, 2014* 20
Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 21
Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014* 22
Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014* 23
Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Nanjing Hospital, 2014* 24
Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Thammasat University, 2014* 25
Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Ahvaz Jundishapur University of Medical Sciences, 2014* 26
Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Heidelberg, 2014* 27
Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Universita degli Studi di Modena e Reggio Emilia, 2014* 28
Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Manipal University, 2014* 29
Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Shriners Hospitals for Children, 2014* 30

List of Figures
Spastic Diplegia Cerebral Palsy Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Spastic Diplegia Cerebral Palsy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Spastic Diplegia Cerebral Palsy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials, Europe, Top Countries (%), 2014* 10
Proportion of Spastic Diplegia Cerebral Palsy to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 13
Spastic Diplegia Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 14
Spastic Diplegia Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 15
Proportion of Spastic Diplegia Cerebral Palsy to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 16
Spastic Diplegia Cerebral Palsy Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 17
Spastic Diplegia Cerebral Palsy Therapeutics, Global, Clinical Trials by Phase (%), 2014* 18
Spastic Diplegia Cerebral Palsy Therapeutics, Global, Clinical Trials by Trial Status, 2014* 19
Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials, Global, by End Point Status, 2014* 20
Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 21
GlobalData Methodology 46

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.